4549 Stock Overview
Engages in the manufacturing and sale of clinical diagnostics in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Eiken Chemical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,150.00 |
| 52 Week High | JP¥2,568.00 |
| 52 Week Low | JP¥1,678.00 |
| Beta | 0.17 |
| 1 Month Change | 2.33% |
| 3 Month Change | -9.24% |
| 1 Year Change | 25.07% |
| 3 Year Change | 12.74% |
| 5 Year Change | 5.65% |
| Change since IPO | 129.95% |
Recent News & Updates
Eiken Chemical (TSE:4549) Is Increasing Its Dividend To ¥27.00
Dec 20
Eiken Chemical's (TSE:4549) Dividend Will Be Increased To ¥27.00
Dec 03Recent updates
Eiken Chemical (TSE:4549) Is Increasing Its Dividend To ¥27.00
Dec 20Eiken Chemical's (TSE:4549) Dividend Will Be Increased To ¥27.00
Dec 03Eiken Chemical (TSE:4549) Is Due To Pay A Dividend Of ¥26.00
Aug 21Revenue Miss: Eiken Chemical Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Aug 03Eiken Chemical (TSE:4549) Will Pay A Dividend Of ¥26.00
Jul 26Eiken Chemical (TSE:4549) Will Pay A Dividend Of ¥26.00
Jul 12Shareholder Returns
| 4549 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 0.3% | -1.4% | -1.5% |
| 1Y | 25.1% | 14.7% | 13.7% |
Return vs Industry: 4549 exceeded the JP Medical Equipment industry which returned 14.7% over the past year.
Return vs Market: 4549 exceeded the JP Market which returned 13.7% over the past year.
Price Volatility
| 4549 volatility | |
|---|---|
| 4549 Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 3.6% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4549 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4549's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1939 | 757 | Tsugunori Notomi | www.eiken.co.jp |
Eiken Chemical Co., Ltd. engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine.
Eiken Chemical Co., Ltd. Fundamentals Summary
| 4549 fundamental statistics | |
|---|---|
| Market cap | JP¥73.96b |
| Earnings (TTM) | JP¥2.33b |
| Revenue (TTM) | JP¥39.52b |
31.8x
P/E Ratio1.9x
P/S RatioIs 4549 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4549 income statement (TTM) | |
|---|---|
| Revenue | JP¥39.52b |
| Cost of Revenue | JP¥23.23b |
| Gross Profit | JP¥16.29b |
| Other Expenses | JP¥13.97b |
| Earnings | JP¥2.33b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 31, 2025
| Earnings per share (EPS) | 67.59 |
| Gross Margin | 41.23% |
| Net Profit Margin | 5.88% |
| Debt/Equity Ratio | 6.5% |
How did 4549 perform over the long term?
See historical performance and comparisonDividends
2.4%
Current Dividend Yield79%
Payout RatioDoes 4549 pay a reliable dividends?
See 4549 dividend history and benchmarks| Eiken Chemical dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 09 2025 |
| Days until Ex dividend | 96 days |
| Days until Dividend pay date | 169 days |
Does 4549 pay a reliable dividends?
See 4549 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 04:58 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eiken Chemical Co., Ltd. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuki Yamazaki | Daiwa Securities Co. Ltd. |
| Masao Yoshida | Ichiyoshi Research Institute Inc. |
| Hironoshin Nomura | Mizuho Securities Co., Ltd. |